Allergan (AGN): Durable Growth For Next Decade Plus - Cowen

June 8, 2017 9:03 AM EDT Send to a Friend
Cowen analyst, Ken Cacciatore, reiterated his Outperform rating on shares of Allergen (NYSE: AGN) after meeting CEO Brent Saunders and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login